The 20 Best Autosomal Dominant Hypocalcemia Doctors Near Me in Ann Arbor, MI

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Advanced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy.

Dr. Gregory Clines is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes (MEND) at the University of Michigan. He received his MD and PhD degrees at the University of Texas Southwestern Medical Center at Dallas. He then completed internal medicine training at Duke University and an endocrinology fellowship at the University of Virginia. Before joining the University of Michigan in 2013, he was on the faculty at the University of Virginia and the University of Alabama at Birmingham.Dr. Clines has been studying and thinking about bone diseases for nearly 30 years. His basic science laboratory studies how novel factors such as hypoxia, androgens, endothelins, Wnt signaling, and other factors regulate the osteoblast-cancer cell synergy in bone metastasis. His other research interests include understanding how sex steroids regulate skeletal size and shape, and the development of novel imaging techniques to assess bone quality.His clinical interests include metabolic and genetic bone diseases as well as general endocrinology. Dr. Clines sees patients at the Metabolism, Endocrinology & Diabetes Clinic (Metabolic Bone Disease Clinic) and at the Ann Arbor Veterans Affairs Medical Center. Dr. Clines is rated as an Advanced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Osteoporosis, Paget's Disease of Bone, Postmenopausal Osteoporosis, Thyroidectomy, and Orchiectomy.

David Olson earned his M.D. and Ph.D. at the University of Michigan (the latter in Cellular and Molecular Biology). He served his internship and residency at Children’s Hospital Boston, followed by a fellowship in pediatric endocrinology and metabolism at Children’s Hospital Boston/Joslin Diabetes Center. Prior to returning to the University of Michigan, Dr. Olson was on staff at Children's Hospital Boston and affiliated with the Department of Newborn Medicine at Brigham and Women’s Hospital. His postdoctoral research was performed at Beth Israel Deaconess Medical Center, Division of Endocrinology. Using novel mouse models, Dr. Olson is exploring gene expression changes in specific neuronal populations in the brain that are known to be important in regulating energy balance; these studies are directed at examining the link between gene expression in specific areas of the brain and altered metabolism. Additional studies using neuron-specific genetic changes are underway to clarify the molecular basis of daily biologic rhythms and explore how disruption of these rhythms predisposes organisms (rodents and humans) to pathologic changes in metabolism. Dr. Olson is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), and Familial Short Stature (FSS).

Brigid Gregg is a Pediatric Endocrinologist and a Pediatrics provider in Ann Arbor, Michigan. Dr. Gregg is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Type 1 Diabetes (T1D), Obesity, Diabetes Insipidus (DI), and Neurohypophyseal Diabetes Insipidus.

Ram Menon is a Pediatric Endocrinologist and a Pediatrics provider in Ann Arbor, Michigan. Dr. Menon is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Type 1 Diabetes (T1D), Congenital Hypothyroidism, Short Stature (Growth Disorders), Pediatric Growth Hormone Deficiency, and Thyroidectomy.

Dr. Napolitano is Professor of Surgery at the University of Michigan School of Medicine, Acute Care Surgery (Trauma, Burns, Critical Care, Emergency Surgery), Program Director of the Surgical Critical Care Fellowship (6 fellows annually) and Associate Chair for the Department of Surgery. Dr. Napolitano is certified by the American Board of Surgery in General Surgery as well as Surgical Critical Care. She is a Fellow of the American College of Surgeons, American College of Critical Care Medicine (ACCM), and the American College of Chest Physicians. Dr. Napolitano is a member and holds leadership positions in numerous professional organizations in surgery, trauma and surgical critical care. Dr. Napolitano is Vice-Chancellor of the Board of Regents of the ACCM. She is past-Chair of the Surgical Section of the Society of Critical Care Medicine (SCCM), and was SCCM Congress Co-Chair in 2006. She served as Chair of the Committee on Perioperative Care for the American College of Surgeons (ACS) from 2003-2005. She is past-Chair of the Multi-Institutional Trials Committee and a member of the Board of Directors for the Eastern Association for the Surgery of Trauma and the Society for the Advancement of Blood Management. She is Secretary of the Surgical Infection Society. She is a member of the American Association for the Surgery of Trauma (AAST) Committee on Acute Care Surgery. She is a member of the Society of University Surgeons, Association of Women Surgeons, and American Surgical Association, among others. She participates nationally in many organizations, and is a member of the Surgical Education and Self-Assessment Program (SESAP) Committee of the ACS and a member of the Steering Committee of the ACS Fundamentals of Surgery Resident Curriculum Committee. She is a member of the national Surgical Care Improvement Project (SCIP) and CMS Technical Expert Panels for Respiratory and Infection, with the goal of reducing surgical complications by 25% by 2010. Dr. Napolitano received the 2002 Association of Women Surgeons Distinguished Member Award, awarded to a member that exemplifies the ideals and mission of the association. Other honors include Surgical Critical Care Educator of the Year Award (1998, 1999, 2000) from University of Maryland, and the Surgery Teacher of the Year Award in 1999 and 2001. She has been a mentor to a number of research fellows at the surgical resident and fellow level and her research group has received numerous awards, including the annual Resident Paper Competition of the ACS Committee on Trauma, SCCM Best Paper award, and numerous others. Dr. Napolitano has authored over 120 peer-reviewed publications, over 50 book chapters, and has been an invited lecturer at many national/international symposia and Visiting Professor at many institutions over the course of her career.Clinical Specialization:Dr. Napolitano's clinical interests are in the areas of general surgery, trauma and surgical critical care. Dr. Napolitano is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Gastrointestinal Fistula, Gastrointestinal Perforation, Appendectomy, and Gallbladder Removal.

Melda Ince is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Ince has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Congenital Generalized Lipodystrophy, Autosomal Dominant Hypocalcemia, Graves Disease, and Thyroid Storm.

Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Debbie Chen is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, and Medullary Thyroid Carcinoma.

Merve Kutahyalioglu M.D., is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology, and Diabetes. She completed her internal medicine internship and residency at the University of Texas Health Science Center, and endocrinology fellowship training at the Baylor College of Medicine. She is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. Dr. Kutahyalioglu joined the faculty at the University of Michigan in 2021. She has an interest in general endocrinology. She is a part of the care team in the MEND Weight Management and MEND Post-Bariatric Surgery Care Program. Dr. Kutahyalioglu is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Malnutrition, Type 1 Diabetes (T1D), Obesity in Children, and Hyperparathyroidism.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes.

Daniyeh Khurram is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Khurram is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, Thrombectomy, and Endoscopy.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Gogineni has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Yu Kuei Alex Lin is a Clinical Assistant Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND). After earning his medical degree at Poznan University of Medical Sciences, Poland, he completed his Medicine Residency at Beth Israel Medical Center, NY, and Endocrinology fellowship at Cleveland Clinic, OH. Dr. Lin joined the faculty at Michigan in 2019.Dr. Lin is a clinical diabetes researcher with research focuses on characterizing hypoglycemia (including evaluating impaired awareness of hypoglycemia and unhelpful hypoglycemia beliefs and management behaviors and their associations with hypoglycemia developments) and devising and testing behavioral interventions for improving hypoglycemia self-management. Dr. Lin’s clinical practice focuses on diabetes and general endocrinology. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Pancreatectomy, and Islet Cell Transplantation.